Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $39
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar has maintained a Neutral rating on Dentsply Sirona (NASDAQ:XRAY) and lowered the price target from $42 to $39.
September 22, 2023 | 12:39 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler has maintained a Neutral rating on Dentsply Sirona and lowered the price target from $42 to $39.
The lowering of the price target by Piper Sandler from $42 to $39 indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100